We first validated the importance of Cxcr4 in AML by transducing Cas9+dsRed+MLL-AF9 leukemia cells with two different sgRNA-expressing vectors targeting Cxcr4 and coexpressing GFP (Figure 2A). The gene discussed is MLLT3; the disease is leukemia.